Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 384

1.

Pharmacogenetics of cardiac inotropy.

Lymperopoulos A, Garcia D, Walklett K.

Pharmacogenomics. 2014 Nov;15(14):1807-1821.

PMID:
25493572
2.

Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.

Yamashita T, Saitoh T, Matsushita M.

J Cardiol. 2014 Nov 6. pii: S0914-5087(14)00284-6. doi: 10.1016/j.jjcc.2014.09.008. [Epub ahead of print]

PMID:
25454208
3.

Atrial fibrillation (acute onset).

Lip GY, Apostolakis S.

BMJ Clin Evid. 2014 Nov 27;2014. pii: 0210.

PMID:
25430048
4.
5.

A patient with systolic dysfunction and an alternating axis.

Miller PE, Scholten EL, Desai CS, Tedford RJ.

JAMA Intern Med. 2014 Dec;174(12):2027-8. doi: 10.1001/jamainternmed.2014.5452. No abstract available.

PMID:
25347012
6.

Management of oral chronic pharmacotherapy in patients hospitalized for acute decompensated heart failure.

Piepoli M, Binno S, Villani GQ, Cabassi A.

Int J Cardiol. 2014 Sep 20;176(2):321-6. doi: 10.1016/j.ijcard.2014.07.085. Epub 2014 Aug 1.

PMID:
25129309
7.

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

Chan BS, Buckley NA.

Clin Toxicol (Phila). 2014 Sep-Oct;52(8):824-36. doi: 10.3109/15563650.2014.943907. Epub 2014 Aug 4. Review.

PMID:
25089630
8.

[Mineralocorticoid receptor antagonists and therapeutic strategies of cardiovascular damage].

Verdugo FJ, Montellano FA, Carreño JE, Marusic ET.

Rev Med Chil. 2014 Jan;142(1):61-71. doi: 10.4067/S0034-98872014000100010. Review. Spanish.

9.

Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.

Parissis JT, Andreoli C, Kadoglou N, Ikonomidis I, Farmakis D, Dimopoulou I, Iliodromitis E, Anastasiou-Nana M, Lainscak M, Ambrosio G, Mebazaa A, Filippatos G, Follath F.

Clin Res Cardiol. 2014 Sep;103(9):733-41. doi: 10.1007/s00392-014-0708-0. Epub 2014 Apr 10.

PMID:
24718849
10.

Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.

Kinugawa K, Nagai R, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T, Hori M; J-Land Investigators.

Adv Ther. 2014 Apr;31(4):426-39. doi: 10.1007/s12325-014-0111-2. Epub 2014 Mar 19. Erratum in: Adv Ther. 2014 May;31(5):577-8.

11.

Drug therapy to reduce early readmission risk in heart failure: ready for prime time?

Vaduganathan M, Fonarow GC, Gheorghiade M.

JACC Heart Fail. 2013 Aug;1(4):361-4. doi: 10.1016/j.jchf.2013.04.010. Epub 2013 Aug 5.

PMID:
24621940
12.

Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.

Murin J, Naditch-Brûlé L, Brette S, Chiang CE, O'Neill J, Steg PG.

PLoS One. 2014 Jan 31;9(1):e86443. doi: 10.1371/journal.pone.0086443. eCollection 2014.

13.

The previous use of digoxin does not worsen early outcome of acute coronary syndromes: an analysis of the ARIAM Registry.

Garcia-Rubira JC, Calvo-Taracido M, Francisco-Aparicio F, Almendro-Delia M, Recio-Mayoral A, Reina Toral A, Aramburu-Bodas O, Gallego García de Vinuesa P, Cruz Fernández JM, Alcántara AG, Hidalgo-Urbano R.

Intern Emerg Med. 2014 Oct;9(7):759-65. doi: 10.1007/s11739-013-1032-9. Epub 2013 Dec 19.

PMID:
24352793
14.

Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.

Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM.

Am J Med. 2014 Jan;127(1):61-70. doi: 10.1016/j.amjmed.2013.08.027. Epub 2013 Nov 18.

15.

Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration.

Benken ST, Lizza BD, Yamout H, Ghossein C.

Am J Health Syst Pharm. 2013 Dec 1;70(23):2105-9. doi: 10.2146/ajhp130171.

PMID:
24249760
16.

Acute Heart Failure Treatment.

Levy PD, Bellou A.

Curr Emerg Hosp Med Rep. 2013 Jun 1;1(2). doi: 10.1007/s40138-013-0012-8.

17.

A case of everolimus-associated chylothorax in a cardiac transplant recipient.

Fukushima N, Saito S, Sakata Y, Sawa Y.

Transplant Proc. 2013 Oct;45(8):3144-6. doi: 10.1016/j.transproceed.2013.08.082.

PMID:
24157052
18.

Management of pericarditis and myocarditis: could heart-rate-reducing drugs hold a promise?

Roubille F, Tournoux F, Roubille C, Merlet N, Davy JM, Rhéaume E, Busseuil D, Tardif JC.

Arch Cardiovasc Dis. 2013 Dec;106(12):672-9. doi: 10.1016/j.acvd.2013.06.047. Epub 2013 Sep 24. Review.

19.

Trends in the medical management of patients with heart failure.

Joffe SW, Dewolf M, Shih J, McManus DD, Spencer FA, Lessard D, Gore JM, Goldberg RJ.

J Clin Med Res. 2013 Jun;5(3):194-204. doi: 10.4021/jocmr1376w. Epub 2013 Apr 23.

20.

Oral flecainide is effective in management of refractory tachycardia in infants.

Kohli V.

Indian Heart J. 2013 Mar-Apr;65(2):168-71. doi: 10.1016/j.ihj.2013.02.009. Epub 2013 Feb 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk